Scarica l'app Stockscreener
6.14
18.76%
0.97
Dopo l'orario di chiusura:
6.30
0.16
+2.61%
Bioage Labs Inc Borsa (BIOA) Ultime notizie
BioAge Labs, Inc. (BIOA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire
Hunterbrook Capital long Bioage Labs, Hunterbrook Media reports - TipRanks
BioAge Labs snags potential half-billion-dollar research deal with NovartisBizwomen - The Business Journals
Aging-focused drug company lands new partner, potential half-billion-dollar payout - The Business Journals
BioAge Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures – Hagens Berman - GlobeNewswire
BIOA SHAREHOLDER REPORT: BioAge Labs Investors are Notified the Company is Being Investigated and are Urged to Contact BFA Law - Newsfile
BioAge and Novartis seek drug targets for ageing-related diseases - Yahoo Finance
BioAge, Novartis team up to discover age-related disease targets - MSN
East Bay aging-focused drug company lands new partner, potential half-billion-dollar payout - The Business Journals
BioAge Labs Announces Multi-Year Collaboration with Novartis - Lifespan.io News
BioAge Labs inks $500 million+ collaboration with Novartis - The Pharma Letter
Bioage Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies That Address Age-Related Diseases and Conditions - Marketscreener.com
BioAge Stock Advances 14% On Novartis Research Collaboration - Marketscreener.com
BioAge, Novartis partner on aging-related drug targets - Investing.com
BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions - The Manila Times
BIOA SHAREHOLDER NOTICE: BioAge Labs Investors are Alerted - GlobeNewswire
BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Kirby McInerney LLP Announces Investigation Against BioAge Labs, Inc. (BIOA) on Behalf of Investors - GlobeNewswire
BIOA INVESTOR NOTICE: BioAge Labs is being Investigated - GlobeNewswire
BIOA INVESTOR NOTICE: BioAge Labs is being Investigated after Discontinuing its Phase 2 Trials -- Contact BFA - EIN News
BIOA INVESTOR ALERT: BioAge Labs Investors are Alerted of Ongoing Investigation into the 76% Stock Drop and are Encouraged to Contact BFA Law - Newsfile
BIOA SHAREHOLDER NOTICE: BioAge Labs is Under Investigation - GlobeNewswire
BIOA SHAREHOLDER NOTICE: BioAge Labs is Under Investigation after the 76% Stock Drop – Contact BFA Law if You Lost Money (NASDAQ:BIOA) - GlobeNewswire Inc.
BIOA SHAREHOLDER NEWS: BioAge Labs, Inc. Investors are Notified of the Ongoing Investigation into the Discontinuation of the Phase 2 Trials – Contact BFA Law - AccessWire
Bronstein, Gewirtz & Grossman, LLC Is Investigating BioAge Labs, Inc. (BIOA) And Encourages Stockholders to Connect - AccessWire
BIOA SHAREHOLDER ALERT: BFA Law Notifies BioAge Labs, Inc. Investors to Contact the Firm about its Ongoing Investigation - Newsfile
BioAge Labs, Inc. (BIOA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - AccessWire
BIOA INVESTIGATION ALERT: BFA Law Alerts BioAge Labs, Inc. - GlobeNewswire
Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More - MSN
SHAREHOLDER ALERT: Investigation of BioAge Labs, Inc. (BIOA) Announced by Holzer & Holzer, LLC - GlobeNewswire
BIOA INVESTIGATION: BFA Law Notifies BioAge Labs, Inc. Investors that it is Investigating the Company after the Stock Plummeted 76% and Urges You to Contact the Firm - Newsfile
BioAge Labs stock faces downgrade with no major data expected until 2026 By Investing.com - Investing.com South Africa
BIOA BREAKING NEWS: BFA Law Announces an Investigation into - GlobeNewswire
BIOA Investors Have Opportunity to Join BioAge Labs, Inc. Securities Fraud Investigation with the Schall Law Firm - PR Newswire
BioAge Labs, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow ... - The Bakersfield Californian
BioAge Labs, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses - GlobeNewswire
BioAge Labs, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover - EIN News
BioAge Labs stock faces downgrade with no major data expected until 2026 - Investing.com Australia
Jefferies Downgrades BioAge Labs (BIOA) - MSN
Citigroup Downgrades BioAge Labs (BIOA) - MSN
BioAge Labs craters after dropping clinical study on top drug candidate for obesity - Mugglehead
BioAge stock downgraded: Citi sees limited upside after trial discontinuation By Investing.com - Investing.com Australia
BioAge halts obesity trial after safety concerns - Longevity.Technology
BioAge’s Hopes For Combo Obesity Drug Dim Due To Liver Safety - Citeline News & Insights
Richmond-based BioAge sees stock fall over 70% after halting obesity drug clinical trial - The Business Journals
Crude Oil Gains 2%; BioAge Labs Shares Plunge - Inkl
Tesla To $370? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
BioAge Labs stock under pressure after Phase II trial termination, says Jefferies - Investing.com India
BioAge halts ongoing Phase II trial of obesity drug due to liver concerns - Yahoo Finance
BioAge's chances slimmer after obesity failure - The Pharma Letter
BioAge Labs, Riot Platforms And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Fresh from IPO, obesity drug developer BioAge hits a hurdle - pharmaphorum
1.61%
1.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):